Virulence and transmission characteristic of H3N8 avian influenza virus circulating in chickens
Evidence Feed
Source-attributed reports as they enter the system, with assessment links and analytical context surfaced for fast review.
Source-attributed reports as they enter the system, with assessment links and analytical context surfaced for fast review.
Public note
For situational awareness and research transparency. Not medical advice.
Virulence and transmission characteristic of H3N8 avian influenza virus circulating in chickens
Virulence and transmission characteristic of H3N8 avian influenza virus circulating in chickens
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i
Investigating high pathogenicity avian influenza virus incursions to remote islands: detection o
Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 v
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i
Investigating high pathogenicity avian influenza virus incursions to remote islands: detection o
Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 v
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i
Investigating high pathogenicity avian influenza virus incursions to remote islands: detection o
Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 v
Analyses of receptor binding specificity of highly pathogenic avian influenza A (H5N1) viruses i
Investigating high pathogenicity avian influenza virus incursions to remote islands: detection o
Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 v
Avian Influenza A(H5N1) - Cambodia. Since then, 83 cases of human infection with influenza A(H5N
Avian Influenza A(H5N1) - Cambodia. See all DONs related to this event Situation at a glance Bet
Avian Influenza A(H5N1) - Mexico. See all DONs related to this event Situation at a glance On 2
Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — California,
Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — California,
Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United State
Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United State
Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 20
Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 20
Vaccination Coverage by Age 24 Months Among Children Born in 2021 and 2022 — National Immu
Vaccination Coverage by Age 24 Months Among Children Born in 2021 and 2022 — National Immu
Increases in Kratom-Related Reports to Poison Centers — National Poison Data System, Unite
Increases in Kratom-Related Reports to Poison Centers — National Poison Data System, Unite
Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2
Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2
Increase in Poison Center Reports Linked to Kratom-Containing Kava Products — National Poi